subscribe Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
Subscribe now
Picture: 123RF/HXDBZXY
Picture: 123RF/HXDBZXY

Medical schemes, including Discovery, are desperate to launch low-cost medical aid products, but the Financial Mail has reported that the regulator is, bizarrely, fighting these plans in court.

Financial Mail editor Rob Rose joins Business Day TV to unpack these low-cost health products and the regulator’s position on what he calls ‘an innovation with little apparent downside.’

Or listen to full audio

Subscribe for free episodes: iono.fm | Apple Podcasts | Spotify | Pocket Casts | Player.fm

subscribe Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
Subscribe now

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.